Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization...
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological...
Johnson & Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the...
Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug...
Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating...
Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. "Our notable full year performance reflects the...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2021 of $1.01 per...
Johnson & Johnson (NYSE: JNJ) announced today that Dr. Nadja West, retired United States Army lieutenant general and former United States Army...
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new pre-recorded fireside chat webcast focused on the company's eye...
Today, Johnson & Johnson Vision* announced findings from a new survey** that assessed awareness of cataracts among adults around the world. Cataracts ...
Johnson & Johnson (NYSE: JNJ) announced today $100 million in commitments and collaborations over the next five years to invest in and promote health ...
Johnson & Johnson (NYSE: JNJ) (the Company) announced the expansion to the partnership between its Janssen Pharmaceutical Companies (Janssen) and the ...
Johnson & Johnson (NYSE: JNJ) will hold a virtual Medical Devices Update for the investment community on Thursday, November 19, 2020, in which...
Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2020 of $1.01 per...
Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. "Our third-quarter results reflect solid performance and positive...
A Johnson & Johnson (NYSE: JNJ) (a Empresa) anunciou hoje que a Comissão Europeia (CE), em nome dos Estados-membros da União Europeia (UE), aprovou...
Johnson & Johnson (NYSE: JNJ) (la compañía) anunció hoy que la Comisión Europea (CE), actuando en nombre de los estados miembros de la Unión Europea...
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States,...
Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. ("Momenta"), a company...
Johnson & Johnson (NYSE: JNJ) (a empresa) anunciou hoje o lançamento da Fase 3 do seu estudo clínico em grande escala, fundamental e multinacional (o ...
Johnson & Johnson (NYSE: JNJ) (la Empresa) anunció hoy el lanzamiento de su ensayo de fase 3 (ENSEMBLE) pivotal, a gran escala y para múltiples...
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its...
Johnson & Johnson today announced that it is accepting applications for its 2021 Women in STEM2D (WiSTEM2D) Scholars Award, aimed at supporting...
Johnson & Johnson (NYSE: JNJ) today announced Lewis Cantley, Ph.D., of Weill Cornell Medicine and NewYork-Presbyterian as the winner of the 2020 Dr....
Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.